Related references
Note: Only part of the references are listed.Therapeutic efficacy of the Ginkgo special extract EGb761 within the framework of the mitochondrial cascade hypothesis of Alzheimer's disease
Walter E. Mueller et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2019)
Exogenous BDNF Increases Mitochondrial pCREB and Alleviates Neuronal Metabolic Defects Following Mechanical Injury in a MPTP-Dependent Way
Zhen Xu et al.
MOLECULAR NEUROBIOLOGY (2018)
Mitochondria as a target for neuroprotection: implications for Alzheimer's disease
Susana Cardoso et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson's disease
Md Zeeshan Rasheed et al.
PROTOPLASMA (2017)
Mitochondria as a target for neuroprotection: implications for Alzheimer's disease
Susana Cardoso et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease
Qian Cai et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Role of Mitochondrial Metabolism in the Control of Early Lineage Progression and Aging Phenotypes in Adult Hippocampal Neurogenesis (vol 93, pg 560, 2017)
Ruth Beckervordersandforth et al.
NEURON (2017)
Mitochondrial Permeability Transition Pore as a Suitable Target for Neuroprotective Agents Against Alzheimer's Disease
Elena F. Shevtsova et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2017)
Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease
Amandine Grimm et al.
BIOGERONTOLOGY (2016)
Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review
Armin von Gunten et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2016)
EGb761 improves cognitive function and regulates inflammatory responses in the APP/PS1 mouse
Wenbin Wan et al.
EXPERIMENTAL GERONTOLOGY (2016)
Altered Energy Metabolism Pathways in the Posterior Cingulate in Young Adult Apolipoprotein E epsilon 4 Carriers
Michelle Perkins et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE epsilon 4 Genotype
Katherine J. Bangen et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment
Eun Hyun Seo et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2016)
Alzheimer, mitochondria and gender
Amandine Grimm et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Synaptosomal Mitochondrial Dysfunction in 5xFAD Mouse Model of Alzheimer's Disease
Lu Wang et al.
PLOS ONE (2016)
Enhanced Neuroplasticity by the Metabolic Enhancer Piracetam Associated with Improved Mitochondrial Dynamics and Altered Permeability Transition Pore Function
Carola Stockburger et al.
NEURAL PLASTICITY (2016)
Mitochondrial Dysfunction in Alzheimer's Disease and the Rationale for Bioenergetics Based Therapies
Isaac G. Onyango et al.
AGING AND DISEASE (2016)
A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam
Carola Stockburger et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Gerwyn Morris et al.
BMC MEDICINE (2015)
Long-term treatment with Ginkgo biloba extract EGb 761 improves symptoms and pathology in a transgenic mouse model of Alzheimer's disease
Xu Liu et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Physiological and Pathological Roles of the Mitochondrial Permeability Transition Pore in the Heart
Jennifer Q. Kwong et al.
CELL METABOLISM (2015)
Novel Sites of Neuroprotective Action of Dimebon (Latrepirdine)
Aleksey Ustyugov et al.
MOLECULAR NEUROBIOLOGY (2015)
The case for rejecting the amyloid cascade hypothesis
Karl Herrup
NATURE NEUROSCIENCE (2015)
Synapses, spines and kinases in mammalian learning and memory, and the impact of aging
Eddy A. van der Zee
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
Procognitive Compounds Promote Neurite Outgrowth
Matthew Page et al.
PHARMACOLOGY (2015)
A review on mitochondrial restorative mechanism of antioxidants in Alzheimer's disease and other neurological conditions
Anil Kumar et al.
FRONTIERS IN PHARMACOLOGY (2015)
Rice Bran Extract Compensates Mitochondrial Dysfunction in a Cellular Model of Early Alzheimer's Disease
Stephanie Hagl et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Synergistic Exacerbation of Mitochondrial and Synaptic Dysfunction and Resultant Learning and Memory Deficit in a Mouse Model of Diabetic Alzheimer's Disease
Yongfu Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Targeting the Prodromal Stage of Alzheimer's Disease: Bioenergetic and Mitochondrial Opportunities
Charles C. Caldwell et al.
NEUROTHERAPEUTICS (2015)
Systematic Review of the Relationship between Amyloid-β Levels and Measures of Transgenic Mouse Cognitive Deficit in Alzheimer's Disease
Avery M. Foley et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis
Michael A. Castello et al.
AGEING RESEARCH REVIEWS (2014)
The amyloid hypothesis, time to move on: Amyloid is the downstream result, not cause, of Alzheimer's disease
David A. Drachman
ALZHEIMERS & DEMENTIA (2014)
A Critique of the Drug Discovery and Phase 3 Clinical Programs Targeting the Amyloid Hypothesis for Alzheimer Disease
Eric Karran et al.
ANNALS OF NEUROLOGY (2014)
Alzheimer disease therapeutics: Focus on the disease and not just plaques and tangles
Khalid Iqbal et al.
BIOCHEMICAL PHARMACOLOGY (2014)
The Alzheimer's disease mitochondrial cascade hypothesis: Progress and perspectives
Russell H. Swerdlow et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Mitochondrial permeability transition pore is a potential drug target for neurodegeneration
Valasani Koteswara Rao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Dimebon Attenuates the A beta-Induced Mitochondrial Permeabilization
Elena F. Shevtsova et al.
CURRENT ALZHEIMER RESEARCH (2014)
A Cell Model for the Initial Phase of Sporadic Alzheimer's Disease
Carola Stockburger et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Effects of standardized extract of Ginkgo biloba leaves EGb761 on mitochondrial functions: mechanism(s) of action and dependence on the source of mitochondria and respiratory substrate
Giedre Baliutyte et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2014)
Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study
Clifford R. Jack et al.
LANCET NEUROLOGY (2014)
Mitochondrial Dysfunction: Different Routes to Alzheimer's Disease Therapy
Pasquale Picone et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
EGb761 Provides a Protective Effect against Aβ1-42 Oligomer-Induced Cell Damage and Blood-Brain Barrier Disruption in an In Vitro bEnd.3 Endothelial Model
Wen-bin Wan et al.
PLOS ONE (2014)
Protective effect and mechanism of Ginkgo biloba extract-EGb 761 on STZ-induced diabetic cardiomyopathy in rats
Arminder Singh Saini et al.
PHARMACOGNOSY MAGAZINE (2014)
Effect of piracetam on the cognitive performance of patients undergoing coronary bypass surgery: A meta-analysis
Yu Fang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
Efficacy and tolerability of Ginkgo biloba extract EGb 761 (R) in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials
Serge Gauthier et al.
CLINICAL INTERVENTIONS IN AGING (2014)
Improvement of mitochondrial function and dynamics by the metabolic enhancer piracetam
Carola Stockburger et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
Key Role of Mitochondria in Alzheimer's Disease Synaptic Dysfunction
Virve Cavallucci et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Protective effects of L-carnitine and piracetam against mitochondrial permeability transition and PC3 cell necrosis induced by simvastatin
Rute A. P. Costa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Reduced VDAC1 Protects Against Alzheimer's Disease, Mitochondria, and Synaptic Deficiencies
Maria Manczak et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model
J. W. Steele et al.
MOLECULAR PSYCHIATRY (2013)
Pharmacological approaches to restore mitochondrial function
Penelope A. Andreux et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
SYNAPTIC CHANGES IN ALZHEIMER'S DISEASE AND ITS MODELS
J. Pozueta et al.
NEUROSCIENCE (2013)
The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)
Shannon L. Risacher et al.
FRONTIERS IN AGING NEUROSCIENCE (2013)
Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer’s and other neurodegenerative diseases
P R Bharadwaj et al.
Translational Psychiatry (2013)
Mitofusins and the mitochondrial permeability transition: the potential downside of mitochondrial fusion
Kyriakos N. Papanicolaou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Synaptic Mitochondrial Pathology in Alzheimer's Disease
Heng Du et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Mitochondrion-Derived Reactive Oxygen Species Lead to Enhanced Amyloid Beta Formation
Kristina Leuner et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Down-regulation of OPA1 alters mouse mitochondrial morphology, PTP function, and cardiac adaptation to pressure overload
Jerome Piquereau et al.
CARDIOVASCULAR RESEARCH (2012)
Anhedonic-like traits and lack of affective deficits in 18-month-old C57BL/6 mice: Implications for modeling elderly depression
Ewa Malatynska et al.
EXPERIMENTAL GERONTOLOGY (2012)
Effects of the standardized Ginkgo biloba extract EGb 761® on neuroplasticity
Walter E. Mueller et al.
INTERNATIONAL PSYCHOGERIATRICS (2012)
Dimebon Ameliorates Amyloid-β Induced Impairments of Mitochondrial Form and Function
Schamim H. Eckert et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
The therapeutic potential of mitochondrial channels in cancer, ischemia-reperfusion injury, and neurodegeneration
Pablo M. Peixoto et al.
MITOCHONDRION (2012)
VDAC, a multi-functional mitochondrial protein as a pharmacological target
Varda Shoshan-Barmatz et al.
MITOCHONDRION (2012)
From Mitochondrial Dysfunction to Amyloid Beta Formation: Novel Insights into the Pathogenesis of Alzheimer's Disease
Kristina Leuner et al.
MOLECULAR NEUROBIOLOGY (2012)
Effects of Polyphenols on Brain Ageing and Alzheimer's Disease: Focus on Mitochondria
Sebastian Schaffer et al.
MOLECULAR NEUROBIOLOGY (2012)
Impairments of Synaptic Plasticity in Aged Animals and in Animal Models of Alzheimer's Disease
Marta Balietti et al.
REJUVENATION RESEARCH (2012)
Synapses and Dendritic Spines as Pathogenic Targets in Alzheimer's Disease
Wendou Yu et al.
NEURAL PLASTICITY (2012)
Spines, Plasticity, and Cognition in Alzheimer's Model Mice
Tara Spires-Jones et al.
NEURAL PLASTICITY (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The acute effects of dimebolin, a potential Alzheimer's disease treatment, on working memory in rhesus monkeys
Scott J. Webster et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Dimebolin in Dementia
Deepak Sachdeva et al.
CNS NEUROSCIENCE & THERAPEUTICS (2011)
Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease (vol 10, pg 187, 2011)
D. Kapogiannis et al.
LANCET NEUROLOGY (2011)
Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model
Heng Du et al.
NEUROBIOLOGY OF AGING (2011)
Dimebon Inhibits Calcium-Induced Swelling of Rat Brain Mitochondria But Does Not Alter Calcium Retention or Cytochrome C Release
Kranthi Kumari Naga et al.
NEUROMOLECULAR MEDICINE (2011)
LATREPIRDINE INCREASES CEREBRAL GLUCOSE UTILIZATION IN AGED MICE AS MEASURED BY [18F]-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY
M. Day et al.
NEUROSCIENCE (2011)
Dimebon enhances hippocampus-dependent learning in both appetitive and inhibitory memory tasks in mice
Julie Vignisse et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease
Dimitrios Kapogiannis et al.
LANCET NEUROLOGY (2011)
The mitochondria permeability transition pore complex in the brain with interacting proteins - promising targets for protection in neurodegenerative diseases
Tamara Azarashvili et al.
BIOLOGICAL CHEMISTRY (2010)
The metabolic enhancer piracetam ameliorates the impairment of mitochondrial function and neurite outgrowth induced by ß-amyloid peptide
C. Kurz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Discovery of a Proneurogenic, Neuroprotective Chemical
Andrew A. Pieper et al.
CELL (2010)
A Synergistic Dysfunction of Mitochondrial Fission/Fusion Dynamics and Mitophagy in Alzheimer's Disease
Renato X. Santos et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Amyloid-beta and Mitochondria in Aging and Alzheimer's Disease: Implications for Synaptic Damage and Cognitive Decline
P. Hemachandra Reddy et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Dimebon (Latrepirdine) Enhances Mitochondrial Function and Protects Neuronal Cells from Death
Shouting Zhang et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
The Alzheimer's Disease Mitochondrial Cascade Hypothesis
Russell H. Swerdlow et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Reduced Posterior Cingulate Mitochondrial Activity in Expired Young Adult Carriers of the APOE epsilon 4 Allele, the Major Late-Onset Alzheimer's Susceptibility Gene
Jon Valla et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
New insights into the role of mitochondria in aging: mitochondrial dynamics and more
Arnold Y. Seo et al.
JOURNAL OF CELL SCIENCE (2010)
Cognition-Enhancing Properties of Dimebon in a Rat Novel Object Recognition Task Are Unlikely to Be Associated with Acetylcholinesterase Inhibition or N-Methyl-D-aspartate Receptor Antagonism
Marco Giorgetti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Mitochondrial Dysfunction: Common Final Pathway in Brain Aging and Alzheimer's Disease-Therapeutic Aspects
Walter E. Mueller et al.
MOLECULAR NEUROBIOLOGY (2010)
Ginkgo Biloba Extract Ameliorates Oxidative Phosphorylation Performance and Rescues Aβ-Induced Failure
Virginie Rhein et al.
PLOS ONE (2010)
Regulation and pharmacology of the mitochondrial permeability transition pore
Dmitry B. Zorov et al.
CARDIOVASCULAR RESEARCH (2009)
Pharmacological inhibition of mitochondrial membrane permeabilization for neuroprotection
Toshio Hisatomi et al.
EXPERIMENTAL NEUROLOGY (2009)
Nootropic agents stimulate neurogenesis Brain Cells, Inc.: WO2007104035
Philippe Thupin
EXPERT OPINION ON THERAPEUTIC PATENTS (2009)
Stimulation of Neurogenesis and Synaptogenesis by Bilobalide and Quercetin via Common Final Pathway in Hippocampal Neurons
Flaubert Tchantchou et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease
Xinglong Wang et al.
JOURNAL OF NEUROSCIENCE (2009)
Ultrastructure of the mitochondrion and its bearing on function and bioenergetics
Giovanni Benard et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Dennis J. Selkoe
BEHAVIOURAL BRAIN RESEARCH (2008)
Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study
Rachelle S. Doody et al.
LANCET (2008)
Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease
Heng Du et al.
NATURE MEDICINE (2008)
Mitochondria in Neuroplasticity and Neurological Disorders
Mark P. Mattson et al.
NEURON (2008)
Piracetam improves cognitive deficits caused by chronic cerebral hypoperfusion in rats
Zhi He et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2008)
Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761)
Reham Abdel-Kader et al.
PHARMACOLOGICAL RESEARCH (2007)
Mitochondrial dysfunction in aging and Alzheimer's disease: Strategies to protect neurons
P. Hemachandra Reddy
ANTIOXIDANTS & REDOX SIGNALING (2007)
Mitochondrial dysfunction:: The first domino in brain aging and Alzheimer's disease?
Kristina Leuner et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer's disease
Flaubert Tchantchou et al.
FASEB JOURNAL (2007)
The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis
Andrea Rasola et al.
APOPTOSIS (2007)
Intersection between mitochondrial permeability pores and mitochondrial fusion/fission
Irina G. Gazaryan et al.
NEUROCHEMICAL RESEARCH (2007)
Piracetam improves mitochondrial dysfunction following oxidative stress
U Keil et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Neural plasticity in the ageing brain
SN Burke et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Gradual alteration of mitochondrial structure and function by β-amyloids:: Importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release
AM Aleardi et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2005)
Activated mitofusin 2 signals mitochondrial fusion, interferes with Bax activation, and reduces susceptibility to radical induced depolarization
M Neuspiel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Differential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction
PH Reddy et al.
JOURNAL OF ALZHEIMERS DISEASE (2005)
The nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display nanomolar potencies on permeability transition in brain-derived mitochondria
MJ Hansson et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2004)
A mitochondrial cascade hypthesis for sporadic Alzheimer's disease
RH Swerdlow et al.
MEDICAL HYPOTHESES (2004)
Inhibition of amyloid-β aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761
Y Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Clinical efficacy of piracetam in cognitive impairment: A meta-analysis
T Waegemans et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2002)
The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β-amyloid
S Bastianetto et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Dimebon improves learning in animals with experimental Alzheimer's disease
NN Lermontova et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2000)
Share Paper
